BSEM — Biostem Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- $71.66m
- $47.51m
- $301.83m
Annual cashflow statement for Biostem Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2020 December 31st | 2021 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | PRESS | |
| Standards: | USG | USG | USG | — | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -4.84 | -2.37 | -1.41 | -7.86 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 2.33 | 0.628 | -0.142 | 7.22 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.421 | 0.916 | 0.642 | -3.08 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -1.89 | -0.582 | -0.625 | -3.5 | — |
| Capital Expenditures | -0.156 | — | — | -0.21 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | 0.061 | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.156 | — | 0.061 | -0.21 | — |
| Financing Cash Flow Items | 0.068 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.92 | 0.542 | 0.804 | 3.18 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.128 | -0.04 | 0.24 | -0.533 | — |